PROFIL Study to Investigate the Effect of GPB on NfL Levels in Patients With Corticobasal Syndrome (CBS)

NCT05983588 · clinicaltrials.gov ↗

PHASE2

Phase

ACTIVE_NOT_RECRUITING

Status

32

Enrollment

OTHER

Sponsor class

Conditions

Corticobasal Syndrome (CBS)

Interventions

DRUG: RAVICTI 1.1 g/ml
DRUG: Placebo

Sponsor

Technical University of Munich